Susana Jiménez-Murcia Selected Research

Susana Jiménez-Murcia Research Topics

Disease

21	Gambling (Pathological Gambling) 02/2024 - 05/2011
15	Feeding and Eating Disorders (Eating Disorder) 01/2024 - 09/2009
9	Anorexia Nervosa 01/2024 - 12/2013
8	Food Addiction 01/2024 - 01/2015
8	Obesity 10/2023 - 01/2013
6	Bulimia Nervosa 03/2022 - 01/2008
4	Mental Disorders (Mental Disorder) 08/2022 - 08/2012
4	Weight Loss (Weight Reduction) 08/2021 - 11/2015
4	Cognitive Dysfunction 08/2021 - 01/2017
3	Vomiting 08/2023 - 01/2012
2	Bulimia (Binge Eating) 08/2023 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2021
2	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 09/2022 - 01/2009
2	Compulsive Sexual Behavior Disorder 01/2018 - 01/2015
2	Substance-Related Disorders (Drug Abuse) 12/2014 - 01/2013
1	Thinness 08/2023
1	Insulin Resistance 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Essential Hypertension 01/2023
1	Alzheimer Disease (Alzheimer's Disease) 01/2023
1	Parkinson Disease (Parkinson's Disease) 09/2022
1	Binge-Eating Disorder (Binge Eating Disorder) 03/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Peripheral Arterial Disease 10/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2021
1	Overweight 08/2021
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021
1	COVID-19 01/2021
1	Mania (Manias) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2020
1	Body-Weight Trajectory 11/2017
1	Sleep Deprivation 03/2016
1	Morbid Obesity 11/2015
1	Anorexia 09/2015
1	Body Weight (Weight, Body) 09/2015
1	Starvation 12/2013

Drug/Important Bio-Agent (IBA)

3	EndocannabinoidsIBA 09/2023 - 01/2013
3	LaxativesIBA 08/2023 - 01/2012
3	Insulin (Novolin)FDA Link 01/2023 - 05/2014
3	Illicit Drugs (Recreational Drugs)IBA 12/2022 - 03/2022
3	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2019
3	OrexinsIBA 01/2019 - 03/2016
3	Peptides (Polypeptides)IBA 01/2019 - 02/2016
2	AdiponectinIBA 02/2024 - 01/2024
2	LeptinIBA 01/2024 - 12/2023
2	Hormones (Hormone)IBA 12/2023 - 11/2019
2	anandamide (arachidonylethanolamide)IBA 11/2023 - 01/2023
2	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 11/2023 - 01/2023
2	DiureticsIBA 08/2023 - 11/2020
2	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 01/2021
2	GhrelinIBA 11/2019 - 02/2016
2	Immunoglobulin D (IgD)IBA 01/2018 - 12/2017
1	PrebioticsIBA 01/2024
1	Complement System Proteins (Complement)IBA 10/2023
1	mesoglycanIBA 06/2023
1	Dopamine Agonists (Dopamine Agonist)IBA 09/2022
1	Anabolic Androgenic SteroidsIBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 08/2021
1	Coffee FDA Link 08/2021
1	Clomipramine (Anafranil)FDA LinkGeneric 01/2021
1	Antidepressive Agents (Antidepressants)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	LipidsIBA 01/2019
1	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 11/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017
1	Peptide YYIBA 02/2016
1	Cholecystokinin (Pancreozymin)IBA 02/2016
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Angiopoietin-Like Protein 8IBA 09/2015
1	HDL LipoproteinsIBA 09/2015
1	N 30IBA 01/2015
1	Dopamine (Intropin)FDA LinkGeneric 12/2014
1	AdipokinesIBA 12/2013

Therapy/Procedure

20	Therapeutics 11/2023 - 01/2008
4	Mediterranean Diet 01/2022 - 07/2017
4	Bariatric Surgery 01/2020 - 11/2015
1	Duration of Therapy 01/2021
1	Glycemic Control 01/2021
1	Withholding Treatment 01/2019
1	Ambulatory Care (Outpatient Care) 01/2019
1	Transcranial Direct Current Stimulation 01/2015